Clinical trial
Treatment of Upper Extremity Deep-Vein Thrombosis
NCT00245856 · University of Oklahoma, Other · Completed
Key facts
| NCT number | NCT00245856 |
|---|---|
| Title | Treatment of Upper Extremity Deep-Vein Thrombosis |
| Official title | Treatment of Upper Extremity Deep-Vein Thrombosis |
| Lead sponsor | University of Oklahoma, Other |
| Collaborators | Pfizer Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Deep-Vein Thrombosis |
| Intervention type | Drug |
| Interventions | Dalteparin sodium injection, Warfarin |
| Enrollment | 67 |
| Start date | Sep 1, 2002 |
| Primary completion | Mar 1, 2009 |
| Completion | Dec 1, 2011 |
| First posted | Oct 28, 2005 |
| Last update posted | Feb 21, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: